Kelly Timothy P's Form 4 filing
Caribou Biosciences, Inc. (CRBU) · filed Feb 24, 2026
- Accession no.
- 0001754067-26-000002
- Filed
- Feb 24, 2026
- Trade date
- Feb 20-24, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.17K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kelly Timothy PCIK 0001754067 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | AGrant or awardAcquired | +45,000 | $0.00 | $0 | 82,500 | Direct | |
| Feb 24, 2026 | Common Stock | SSaleDisposed | −3,147 | $1.96 | −$6,168.12 | 79,353 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | AGrant or awardAcquired | +202,500 | $0.00 | $0 | 202,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.